Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Net Margin (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Net Margin for 9 consecutive years, with 50.56% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 3587.0% to 50.56% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 15.94% through Dec 2025, up 927.0% year-over-year, with the annual reading at 15.95% for FY2025, 928.0% up from the prior year.
  • Net Margin hit 50.56% in Q4 2025 for Inspire Medical Systems, up from 4.42% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 50.56% in Q4 2025 to a low of 40.19% in Q1 2021.
  • Historically, Net Margin has averaged 3.9% across 5 years, with a median of 4.28% in 2021.
  • Biggest five-year swings in Net Margin: surged 16485bps in 2021 and later tumbled -665bps in 2025.
  • Year by year, Net Margin stood at 2.99% in 2021, then skyrocketed by 176bps to 2.28% in 2022, then skyrocketed by 236bps to 7.68% in 2023, then soared by 91bps to 14.69% in 2024, then skyrocketed by 244bps to 50.56% in 2025.
  • Business Quant data shows Net Margin for INSP at 50.56% in Q4 2025, 4.42% in Q3 2025, and 1.67% in Q2 2025.